CopyMark Law Group
4.9/5
Drawing for A

USPTO serial 87719576

A

Reviewed by CopyMark Law Group

Reg. 5698700Status 702Registered
Filing date
Status date
Registration date
Mar 12, 2019
Examiner
RICHARDS, SUSAN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with A?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carrie Webb Olson

Carrie Webb Olson DAY PITNEY LLPOne Federal Street, 29th FloorBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of drugs and pharmaceuticals to humansACTIVENov 28, 2018
042Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and developmentACTIVENov 30, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 17, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 17, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 17, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 27, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jul 26, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 12, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 25, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 25, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 25, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 12, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 6, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 5, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 15, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 15, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 14, 2018IUAFUSE AMENDMENT FILED—
Dec 14, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 26, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 1, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 1, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2018DOCKASSIGNED TO EXAMINER—
Jan 31, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 28, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance